| A Phase 3, Bridging, Multicenter, Randomized, Double-blind, Placebo-controlled, Parallel-group Trial to Evaluate the Efficacy and Safety of Subcutaneously Administered Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (With or Without Decreased Arousal) (NCT04943068) | Kwang Dong Pharmaceutical co., ltd. | 2021-05-10 |
| Improving Female Sexual Wellness (NCT04824820) | Cedars-Sinai Medical Center | 2021-04-10 |
| A Mindfulness-based Intervention for Older Women With Low Sexual Desire (NCT03232801) | University of Pittsburgh | 2020-10-08 |
| Role of the Melanocortin-4 Receptor in Hypoactive Sexual Desire Disorder (NCT04179734) | Imperial College Healthcare NHS Trust | 2019-10-07 |
| Effect of Testosterone Treatment on Clitoral Arteries' Hemodynamic Parameters. (NCT04336891) | University of Florence | 2019-03-20 |
| Waitlist Controlled Comparison of Cognitive-behavioral vs. Mindfulness-based Online-treatments for Women With Low Sexual Desire (NCT03780751) | Ruhr University of Bochum | 2018-12-18 |
| BP101 for Adults With Female Sexual Dysfunction (NCT03463707) | Ivix LLX | 2018-03-05 |
| Prasterone (DHEA) for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) (NCT03287232) | EndoCeutics Inc. | 2017-10-16 |
| Flibanserin (Addyi®) vs. Flibanserin and Sex Therapy (NCT02714049) | San Diego Sexual Medicine | 2017-01-25 |
| Effects of Flibanserin on the Pre- and Post-menopausal Female Brain (NCT02770768) | University of Chicago | 2016-10-01 |
| Role of Progesterone in Hypoactive Sexual Desire Disorder in Menopausal Women (NCT02968342) | Bezmialem Vakif University | 2016-07-01 |
| A Study Evaluating the Effects of Topical Clitoral Estradiol Cream in Post Menopausal Women (NCT02859285) | ProHealth Care, Inc | 2016-04-01 |
| Bupropion in Sexual Dysfunction Among Methadone Maintenance Treatment Men (NCT02593396) | University of Malaya | 2015-12-01 |
| 2. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (NCT02338960) | Palatin Technologies, Inc | 2015-01-01 |
| The Effect of Individualised Homeopathic Treatment on Low Sexual Desire in Perimenopause (NCT02419209) | University of Johannesburg | 2015-01-01 |
| 1. Study to Evaluate the Efficacy/Safety of Bremelanotide in Premenopausal Women With Hypoactive Sexual Desire Disorder (NCT02333071) | Palatin Technologies, Inc | 2014-12-01 |
| Low Sexual Desire and Metabolic Syndrome (NCT02430987) | Faculdade de Ciências Médicas da Santa Casa de São Paulo | 2014-09-01 |
| Lybridos in Pre-and Postmenopausal Women With Hypoactive Sexual Desire Disorder (NCT02101203) | Emotional Brain NY Inc. | 2013-07-01 |
| Lybridos in Pre- and Postmenopausal Women With Hypoactive Sexual Desire Disorder Due to Maladaptive Activation of Sexual Inhibitory Systems (NCT01743235) | Emotional Brain NY Inc. | 2012-07-01 |
| Lybrido for Female Sexual Dysfunction (NCT01432665) | Emotional Brain NY Inc. | 2011-09-01 |
| Bremelanotide in Premenopausal Women With Female Sexual Arousal Disorder and/or Hypoactive Sexual Desire Disorder (NCT01382719) | Palatin Technologies, Inc | 2011-06-01 |
| A Combined Psycho-pharmacological and Brain Imaging Study of Human Sexuality (NCT00569413) | Hadassah Medical Organization | 2011-04-01 |
| Testosterone Patch's Effects on the Cardiovascular System and Libido (NCT01208038) | Imperial College Healthcare NHS Trust | 2011-03-01 |
| Extension Study to Assess Persistence of Benefit of LibiGel for the Treatment of Hypoactive Sexual Desire Disorder (HSDD) (NCT01235754) | BioSante Pharmaceuticals | 2010-10-01 |
| A Pharmacokinetic (PK) Study to Compare the Absorption of Two Formulations of Transdermal Testosterone Spray and Intrinsa® (NCT01096329) | VIVUS LLC | 2010-02-01 |
| Safety and Efficacy of LibiGel® for Treatment of Hypoactive Sexual Desire Disorder in Postmenopausal Women (NCT00612742) | BioSante Pharmaceuticals | 2008-01-01 |
| Surveillance Study of Women Taking Intrinsa® (NCT00551785) | Center for Epidemiology and Health Research, Germany | 2007-09-01 |
| Endometrial Safety Study of Transdermal Testosterone (300 Mcg/Day) in Naturally Postmenopausal Women (NCT00467259) | Warner Chilcott | 2007-04-01 |
| Safety and Efficacy of LibiGel® for the Treatment of Hypoactive Sexual Desire Disorder in Surgically Menopausal Women (NCT00613002) | BioSante Pharmaceuticals | 2006-12-01 |
| Sexual Dysfunction and Dental Care (NCT00281372) | Sheba Medical Center | 2006-02-01 |
| Dehydroepiandrosterone (DHEA) Treatment in Women and Men Experiencing Hypoactive Sexual Desire Disorder (NCT00916396) | Tel-Aviv Sourasky Medical Center | 2005-06-01 |
| Testosterone in Female Hypoactive Sexual Desire Disorder (NCT00140153) | Beersheva Mental Health Center | 2005-04-01 |
| Effects of Early Abuse on Adult Intimate Relationships (NCT01803802) | University of Texas at Austin | 2005-04-01 |
| Study of Transdermal Testosterone Patches in Menopausal Women With Low Libido (NCT00131495) | Warner Chilcott | 2004-07-01 |
| Ginkgo Biloba: Antidepressant-Induced Sexual Dysfunction (NCT00034021) | National Center for Complementary and Integrative Health (NCCIH) | 2002-06-01 |
| Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido (NCT00331214) | Warner Chilcott | 2002-06-01 |
| Study of Transdermal Testosterone Patches in Naturally Menopausal Women With Low Libido (NCT00338312) | Warner Chilcott | 2002-06-01 |
| Study of Transdermal Testosterone Patches in Surgically Menopausal Women With Low Libido (NCT00331123) | Warner Chilcott | 2002-05-01 |